bisbenzimidazole and 7,3'-dihydroxy-4'-methoxyisoflavone

bisbenzimidazole has been researched along with 7,3'-dihydroxy-4'-methoxyisoflavone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, J; Chen, Y; Gao, H; Hu, S; Li, Y; Tian, J; Zhang, X	1

Other Studies

1 other study(ies) available for bisbenzimidazole and 7,3'-dihydroxy-4'-methoxyisoflavone

Article	Year
Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2023, Volume: 118 Topics: Bisbenzimidazole; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Humans; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptors, Estrogen; Signal Transduction; Sincalide; Triple Negative Breast Neoplasms	2023

Article

Year

Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.

Phytomedicine : international journal of phytotherapy and phytopharmacology, 2023, Volume: 118

Topics: Bisbenzimidazole; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Humans; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptors, Estrogen; Signal Transduction; Sincalide; Triple Negative Breast Neoplasms

2023